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Summary
Glial cells are crucial regulators of synapse formation,
elimination, and plasticity [1, 2]. In vitro studies have begun
to identify glial-derived synaptogenic factors [1], but neuron-
glia signaling events during synapse formation in vivo
remain poorly defined. The coordinated development of
pre- and postsynaptic compartments at the Drosophila
neuromuscular junction (NMJ) depends on a muscle-
secreted retrograde signal, the TGF-b/BMP Glass bottom
boat (Gbb) [3, 4]. Muscle-derived Gbb activates the TGF-b
receptors Wishful thinking (Wit) and either Saxophone
(Sax) or Thick veins (Tkv) in motor neurons [3, 4]. This
induces phosphorylation of Mad (P-Mad) in motor neurons,
its translocation into the nucleuswith a co-Smad, and activa-
tion of transcriptional programs controlling presynaptic
bouton growth [5]. Here we show that NMJ glia release
the TGF-b ligand Maverick (Mav), which likely activates the
muscle activin-type receptor Punt to potently modulate
Gbb-dependent retrograde signaling and synaptic growth.
Loss of glial Mav results in strikingly reduced P-Mad at
NMJs, decreased Gbb transcription in muscle, and in turn
reduced muscle-to-motor neuron retrograde TGF-b/BMP
signaling. We propose that by controlling Gbb release from
muscle, glial cells fine tune the ability of motor neurons
to extend new synaptic boutons in correlation to muscle
growth. Our work identifies a novel glia-derived synapto-
genic factor by which glia modulate synapse formation
in vivo.Results and Discussion
A TGF-b Signaling Pathway Is Activated by Peripheral Glia
during Synapse Development
Given the prominent role of glia and TGF-b signaling during
synaptic bouton formation at the larval neuromuscular junc-
tion (NMJ), we sought to determine whether ligands of the
TGF-b superfamily are expressed in peripheral glia at the
larval stage by real-time PCR (Figures 1A and 1B). For this
analysis, we isolated total RNA from segmental nerves
in which the only cell bodies were peripheral glia and no
neuronal RNAs were detected (Figure 1B). This analysis re-
vealed the presence of several transcripts for TGF-b ligands
in glia, including Myoglianin (MYO), Dawdle (Daw), and
Maverick (Mav) (Figure 1A). In contrast, Activin b (Actb)3These authors contributed equally to this work
*Correspondence: marc.freeman@umassmed.edu (M.F.), vivian.budnik@
umassmed.edu (V.B.)transcripts were not detected in nerves (Figure 1A). To explore
a potential involvement of glia-derived TGF-b ligands in
signaling synaptic development, we expressed RNAi trans-
genes targeting Daw, Mav, and MYO transcripts specifically
in peripheral glia using the Gal4 driver Gli-Gal4 (rl82-Gal4)
[6, 7]. Downregulating Mav and Daw, but not MYO, in NMJ
glia substantially reduced NMJ size, as determined by count-
ing the number of synaptic boutons at the third-instar larval
stage (Figures 1C–1G). In the case of Mav, the number of
branches was also reduced (the number of branches in
Mav-RNAi glia is 9.13 6 0.70 [n = 15] compared with 17.0 6
0.50 [n = 18] in controls).
Glia-Derived Mav Is Required for TGF-b Signaling
at Synaptic Sites
A classical readout of TGF-b pathway activation is Mad phos-
phorylation (P-Mad) [8]. At the Drosophila larval NMJ, TGF-b
activation through P-Mad detection has been documented in
both motor neuron nuclei [3] and synaptic boutons of the
NMJ [9]. At synaptic boutons, P-Mad signal is organized into
discrete puncta decorating synaptic boutons [9] (Figure 1H).
Notably, downregulating Mav in peripheral glia with two
different Mav-RNAi constructs targeting different regions of
the Mav transcript virtually eliminated or severely reduced
P-Mad immunoreactivity at synaptic sites (Figures 1I and
1Q). In contrast, downregulating MYO had no effect (Figures
1J and 1Q). A decrease in P-Mad signal was also observed
by downregulating Daw in glia (Figure 1K), but this effect
was much weaker (Figure 1Q).
To assess whether Mav was exclusively required in glia for
activation of TGF-b signaling, we also expressed Mav-RNAi
in either muscles or motor neurons. However, we observed
no significant change in synaptic P-Mad levels as a result of
these manipulations (Figures 1L, 1M, and 1Q). Thus, Mav is
exclusively required in glia for activation of TGF-b signaling
at synaptic sites. Further evidence for such requirement was
obtained by examining the effect of overexpressing Mav in
glia, which resulted in an increase of P-Mad signal intensity
at the NMJ (Figures 1N–1P, and 1R). Although there was no
significant increase in the number of synaptic boutons at
muscles 6 and 7 (Figure 1S, black bars) in parallel with the
increase in synaptic P-Mad intensity, the number of boutons
at muscle 4 was significantly increased (Figure 1S, white
bars). This increase was primarily due to an increase in the
number of satellite boutons (small boutons emerging from
normally sized synaptic boutons), which were significantly
increased at muscles 6/7 and 4 (Figure 1T).
In contrast to glia, downregulating Mav in motor neurons
or muscles did not significantly change NMJ size (Figure 1C).
Interestingly, in vitro studies of the synaptogenic effects
of Xenopus Schwann cells (SCs) led to the proposal that
SC-derived TGF-b1 could promote synaptogenesis [10].
However, the exact source of the synaptogenic signal was
not clear, and whether TGF-b1 plays a role in the intact
organism remains to be determined [10]. Our observations
provide direct evidence indicating that a glia-derived TGF-b
ligand can influence both TGF-b signaling and synaptic growth
in vivo at the NMJ.
Figure 1. Glial Mav Regulates TGF-b Activation
(A) Real-time PCR products from larval segmental nerve and embryonic RNA, showing that MYO, Daw, and Mav transcripts, but not Actb transcripts, are
detected in nerve glia. * indicates an unspecific product as determined by sequencing (n = 3).
(B) Reverse transcriptase PCR from larval brain and segmental nerve RNA, showing that the neuron-specific transcript elav is present in brain but not in
segmental nerve RNA.
(C) Number of boutons at muscles 6 and 7 (segment A3) of third-instar larvae expressing Mav-RNAi, MYO-RNAi, or Daw-RNAi in NMJ glia (Gli-Gal4) and
Mav-RNAi in neurons (C380-Gal4) or muscles (C57-Gal4), showing that downregulating Mav in NMJ glia reduces bouton number (from left to right,
n = 22, 11, 14, 6, 9, 16, 17).
(D–G) Confocal images of third-instar larval NMJs labeled with anti-HRP in (D) wild-type control and animals expressing (E) Mav-RNAi, (F) MYO-RNAi, or (G)
Daw-RNAi in NMJ glia.
(H–N) Confocal images of NMJ branches in preparations double labeled with anti-HRP and anti-P-Mad in (H) controls and (I–N) larvae expressing (I)
Mav-RNAi, (J) MYO-RNAi, or (K) Daw-RNAi in glia; (L) Mav-RNAi in neurons (C380-Gal4); (M) Mav-RNAi in muscles (C57-Gal4); and (N) Mav in glia, showing
that Mav downregulation in NMJ glia virtually eliminates P-Mad signal and that this signal is enhanced upon Mav overexpression in NMJ glia.
(O and P) High-magnification views of P-Mad staining at synaptic boutons in (O) control and (P) Mav overexpression in glia.
(Q) Percentage of P-Mad positive synaptic boutons in the indicated genotypes (from left to right, n = 18, 11, 14, 6, 12, 11, 12).
(R) Mean P-Mad signal intensity normalized to control in the indicated genotypes (n = 10 for each genotype).
(S and T) Quantification of the number of (S) boutons and (T) satellite boutons at abdominal segment 3 in muscles 6 and 7 (black bars) and 4 (white bars),
in wild-type and Mav glia (from left to right, n = 12 and 17 in both S and T).
Error bars represent mean 6 SEM (***p < 0.001, **p% 0.01, *p% 0.05). Scale bar represents 22 mm for (D)–(G), 4 mm for (H)–(N), and 2.5 mm for (O) and (P).
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The requirement for peripheral glia in TGF-b pathway activa-
tion and synaptic bouton growth led us to predict that periph-
eral glia should be capable of releasing Mav. We generated an
anti-Mav peptide antibody and found that it labeled bright
puncta within peripheral glial cells (Figure 2A), consistent
with our detection of Mav transcript in these cells (Figure 1A).This labeling was specific, because it was almost completely
eliminated by expressing Mav-RNAi1 in peripheral glia
(Figure 2B). To determine whether Mav could be released
by peripheral glia, we generated transgenic flies expressing
a green fluorescent protein (GFP)-tagged Mav transgene and
drove its expression in NMJ glia with the rl82-Gal4 driver.
This transgene was likely to be functional, because it behaved
Figure 2. Mav Is Present in Peripheral Glia and Can Be Secreted by Glia
(A and B) Anti-Mav labeling of larval segmental nerves in anti-HRP and Mav double-labeled preparations in (A) wild-type and (B) larvae expressing Mav-
RNAi-1 in peripheral glia, showing the presence of endogenous Mav in peripheral glia (arrowheads). Insets show high-magnification views of a segmental
nerve region.
(C) Distribution of transgenic Mav-GFP in peripheral glia in a preparation also expressing mCherry in peripheral glia and double labeled with antibodies to
HRP and GFP, showing punctate GFP label similar to endogenous Mav (arrowheads).
(D) Mav-GFP expressed in peripheral glia shows strong punctate GFP label within NMJ glial extensions (arrowhead) as well as associated with NMJ regions
devoid of glial membranes (arrow).
(E–G) High-magnification views of NMJ branches labeled with anti-HRP and anti-GFP showing the distribution of Mav-GFP when expressed in (E) NMJ glia,
(F) neurons, and (G) muscles. Only when Mav-GFP is expressed in glia is it observed outside of the producing cell.
Scale bar represents 15 mm for (A)–(C), 12 mm for (D), and 5 mm for (E)–(G).
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the GFP-tagged transgene in glia induced a significant
increase in the number of boutons and satellite boutons (the
number of boutons at muscle 4 is 63.3 6 3.7 when Mav-GFP
is expressed in glia [n = 18], compared with 62.1 6 3.1 when
untagged Mav is expressed in glia [n = 17], and 39.5 6 2.0 in
controls [n = 12]; the number of satellite boutons at muscle 4
is 19.5 6 1.5 when Mav-GFP is expressed in glia [n = 18],
compared with 19.8 6 1.1 when untagged Mav is expressed
in glia [n = 17] and 5.56 0.9 in controls [n = 12]). As with endog-
enous Mav, Mav-GFP became distributed in bright GFP
puncta within glia in the segmental nerves (Figure 2C). In addi-
tion, Mav-GFP was prominent at glial extensions that interact
with the NMJ (Figure 2D, arrowhead), showing that Mav-GFP
is efficiently transported to these glial extensions. Notably,
bright GFP puncta were also observed beyond the boundary
of glial extensions (Figures 2D and 2E), indicating that Mav-GFP could be released by peripheral glial cells. Close obser-
vation of the Mav-GFP puncta outside the glial membrane
extensions revealed their localization in close association
with both synaptic boutons and the postsynaptic junctional
region of the muscle (Figure 2E, arrows). In contrast, express-
ing Mav-GFP in neurons resulted in punctate and diffuse GFP
staining within synaptic boutons, but no GFP signal was
observed beyond the boundary of synaptic boutons (Fig-
ure 2F), showing that Mav-GFP is likely not released from
synaptic boutons. Similarly, expressing Mav-GFP in muscles
resulted in very dim GFP signal in muscle cells, but this signal
did not localize to the NMJ (Figure 2G). Thus, Mav mRNA and
protein are present in peripheral glia, glia can secrete trans-
genic Mav, and secreted Mav associates with synaptic bou-
tons and muscles. Our previous studies demonstrated that
peripheral glial membrane extensions at the NMJ are dynamic,
extending and retracting processes that become associated
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1834with synaptic boutons andmuscles [6]. Therefore, it is possible
that glial membrane extensions might directly deposit Mav
as they dynamically interact with boutons or muscles. Alterna-
tively, glia-derivedMavmay be released from these processes
and diffuse to relatively distant sites.
Synaptic TGF-b Signaling Is Activated Both
Pre- and Postsynaptically
The finding that glia can release Mav, and that glia-derived
Mav is required for TGF-b signaling at synaptic sites, raised
the question as to which cells (neurons or muscles) respond
to Mav. The synaptic P-Mad signal is virtually absent when
Mav is downregulated in glia. However, whether the P-Mad
signal is pre- or postsynaptic has been a matter of debate.
One study reported that synaptic P-Mad partially colocalized
with the presynaptic active zone marker Bruchpilot (BRP)
while it did not colocalize with Discs-large (DLG), suggesting
that P-Mad is presynaptic [11]. However, DLG is localized at
the perisynaptic region within the pre- and postsynaptic
compartments [12], and thus it is not expected to colocalize
with the postsynaptic density. Another study reported that in
wit mutants, the synaptic P-Mad signal was eliminated [13].
Given the role of Wit receptors in activating TGF-b signaling
in motor neurons, it was concluded that P-Mad was presyn-
aptic. However, whether Wit is also expressed in muscles is
unknown. In a third report, the synaptic P-Mad signal was
found to completely colocalize with a tagged glutamate
receptor GluRIIA transgene, which suggested a postsynaptic
P-Mad localization [9]. However, a comparison with endoge-
nous GluRs was not done. To address this issue more directly,
we first used a strong hypomorphic mad mutant, mad12, over
a mad deficiency chromosome (mad12/Df) and examined
P-Mad labeling at the NMJ. P-Mad immunoreactivity was
completely eliminated in this mutant (Figures 3A and 3B),
providing direct evidence for the specificity of the P-Mad
signal we observe at the NMJ. We then downregulated Mad
in either motor neurons or muscles by expressing Mad-RNAi
and examined the intensity of the synaptic P-Mad signal. We
found that downregulating Mad in either neurons or muscles
resulted in a significant decrease in P-Mad signal intensity
(Figures 3C and 3E–3G), suggesting both a presynaptic and
postsynaptic localization of P-Mad. Importantly, the number
of synaptic boutons was significantly reduced by downregula-
tion of Mad in either neurons or muscles (Figure 3D), arguing
strongly for a requirement for Mad function in both cell types.
We also examined the localization of P-Mad in comparison
with the endogenous localization of GluRIIA and BRP. Con-
firming previous reports with the GluRIIA transgene, we found
that synaptic P-Madwas always present within the boundaries
of endogenous GluRIIA clusters (Figures 3H, 3I, and 3M). In
contrast, only partial colocalization between BRP and P-Mad
was observed, and the signals appeared juxtaposed (Figures
3J–3L). However, given that active zones and postsynaptic
GluR clusters are apposed to each other in close proximity
(<40 nm), we note that light microscopy alone cannot resolve
this issue. Nevertheless, the finding that downregulating Mad
in either muscles or neurons leads to both P-Mad reduction
and NMJ growth defects (Figures 3C and 3E–3G) is a strong
indication that the signal is localized to both types of cells.
Glia-Derived Mav Activates Dad and Gbb Transcription
in Muscle Cells
The finding that synaptic P-Mad can be attributed to muscles
in addition to neurons, and that this signal is virtuallyeliminated by downregulating Mav in NMJ glia, provided
compelling evidence that a TGF-b signal is activated in
muscles as previously proposed [9]. To confirm this finding,
we used an additional reporter of TGF-b pathway activation,
the transcription of daughters against dpp (Dad), an inhibitory
Smad that antagonizes TGF-b signaling [9, 14]. Real-time PCR
from larval body wall muscle RNA demonstrated that dad
transcript was significantly decreased upon expression of
Mav-RNAi in glia (Figure 4A), providing additional support
for a role of glia-derived Mav in activating TGF-b signaling in
muscles.
It has been previously reported that the transcription of the
Glass bottom boat (Gbb) retrograde ligand is also regulated
by TGF-b pathway activation [15]. Interestingly, downregulat-
ing Mav in glia resulted in a significant decrease in muscle
gbb transcript levels (Figure 4A). In contrast, cyclophilin
control transcript levels were not affected (Figure 4C). This
observation raised the possibility that glial cells could modu-
late the intensity of the retrograde signal. To test this model,
we examined P-Mad levels in the nuclei of motor neurons (a
readout for retrograde TGF-b pathway activation). Expression
of Mad-RNAi in motor neurons led to a drastic decrease in
P-Mad immunoreactivity at motor neuron nuclei, demon-
strating that the P-Mad signal at this site is specific (Figures
4B, 4D, and 4E). Most importantly, and consistent with our
model, P-Mad immunoreactivity levels were significantly
decreased in the nuclei of larval motor neurons when Mav-
RNAi, but not MYO-RNAi or Daw-RNAi, was expressed in
peripheral glia (Figures 4B, 4D, and 4F).
Finally, we also examined the levels of a TGF-b target gene
in motor neurons, Trio [5]. Trio is a Rac-activating protein
that contributes to cytoskeletal remodeling during synaptic
growth. Previous studies demonstrated that upon activation
of motor neuron TGF-b signaling by muscle Gbb, trio tran-
scription is upregulated [5, 16]. Real-time PCR revealed that
trio transcript levels were significantly reduced in RNA isolated
from larval brainswhenMav-RNAiwas expressed in peripheral
glia (Figure 4C). In contrast, cyclophilin control transcript
levels were unchanged by this manipulation (Figure 4C). These
results provide strong evidence that glia-derived Mav also
modulates motor neuron TGF-b signaling. This modulation
might occur through direct interaction of Mav with TGF-b
receptors in motor neurons, or by regulating the levels of
Gbb in muscles, leading to a change in Gbb release.
In support of the above model, we found that Mav function
in NMJ development depended on Gbb. As noted, overex-
pressing Mav in glia results in a significant increase in the
number of boutons (Figures 1S and 4G). In contrast, no change
in bouton number was observed in gbb/+ heterozygous larvae
(Figure 4G). Notably, the increase in bouton number observed
upon overexpression of Mav in glia was completely sup-
pressed in gbb/+ heterozygous larvae (Figure 4G). These
results point to a role of Gbb in mediating the response to
glia-derived Mav during NMJ development.
We also found evidence pointing to Punt as the likely
receptor mediating the muscle response to glia-derived Mav.
Downregulating Punt in muscle using two different RNAi lines
targeted to different regions of Punt and the C57-Gal4 driver
resulted in a substantial decrease in bouton number compared
with the driver control (Figure 4H). In addition, downregulating
Punt in muscle decreased the levels of P-Mad immunoreac-
tivity in motor neuron nuclei (Figure 4I).
In summary, our studies provide direct in vivo evidence that
glial cells secrete a TGF-b ligand, Mav, that influences the
Figure 3. Mad Is Activated in Both Pre- and Postsynaptic Cells at the NMJ
(A and B) NMJs double labeled with antibodies to HRP and P-Mad in (A) wild-type and (B) mad12/Df, showing that P-Mad immunoreactivity at the NMJ
is specific.
(C) P-Mad signal intensity in the indicated genotypes, showing that P-Mad signal is reduced by downregulatingMad in either neurons ormuscles (from left to
right: n = 11, 7, 8).
(D) Number of boutons in the indicated genotypes, showing that interfering with Mad function in either muscles or neurons reduces NMJ size (from left to
right, n = 25, 24, 16).
(E–G) NMJ arbors double labeled with anti-HRP and P-Mad antibodies in (E) wild-type and larvae expressing Mad-RNAi in either (F) neurons or (G) muscles.
(H–K) NMJs double labeled with anti-HRP, anti-P-Mad, and (H and I) anti-GluRIIA or (J and K) anti-Brp, showing that P-Mad is completely encompassed by
GluRIIA immunoreactivity and juxtaposed to Brp immunoreactivity. (I) and (K) are high-magnification views of a single bouton.
(L andM) Fluorescence intensity profiles across themidline of a bouton showing (L) shifted profiles betweenBrp and P-Mad and (M) a similar profile between
GluRIIA and P-Mad.
Error bars represent mean6 SEM (***p < 0.001, **p% 0.01, *p% 0.05). Scale bar represents 25 mm for (A) and (B), 3 mm for (E)–(G), 7 mm for (H) and (J), and
2.5 mm for (I) and (K).
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grade signaling. By controlling TGF-b signaling in both
muscles and neurons, glial cells are well positioned to inte-
grate the coordinated development of pre- and postsynaptic
compartments.It is interesting to note, however, that there could be partial
redundancy between the two activin-type ligands, Mav and
Daw, because glial knockdown of either leads to decreased
NMJ growth (Figure 1C) and synaptic P-Mad (Figure 1Q),
although the effect of Mav downregulation is substantially
Figure 4. Regulation of Retrograde Signaling by
Glia-Derived Mav
(A) Real-time PCR of larval muscle RNA, showing
that dad and gbb transcripts are significantly
decreased inmuscle whenMav is downregulated
in NMJ glia (n = 3).
(B) Normalized P-Mad intensity in motor neuron
nuclei in the indicated genotypes, showing that
Mav downregulation in glia results in a reduction
in P-Mad levels in neurons (from left to right, n =
12, 11, 10, 8, 9).
(C) Real-time PCR of larval brain RNA, showing
that Trio transcript is reduced in brain when
Mav is downregulated in glia (n = 3).
(D–F) View of larval ventral ganglia shown at
(D1–F1) low and (D2–F2) high magnification in
preparations double labeled with anti-Elav and
anti-P-Mad antibodies in (D) wild-type and larvae
expressing (E) Mad-RNAi in neurons or (F) Mav-
RNAi in peripheral glia.
(G) Number of boutons on muscle 4 (segment A3)
in the indicated genotypes, demonstrating that
removal of a single copy of gbb suppresses the
effect of overexpressing Mav-GFP in glia (from
left to right, n = 11, 12, 12, 13, 18, 12).
(H) Normalized number of boutons on muscles 6
and 7 in controls (UAS-Punt-RNAi/+) or in larvae
expressing the Punt-RNAi constructs using
C57-Gal4 (Punt-RNAi-muscle). Samples were
normalized to their respective controls to allow
direct comparisons (from left to right, n = 12, 13,
10, 12).
(I) Normalized P-Mad intensity in motor neuron
nuclei in control and Punt-RNAi-1-muscle
samples, showing reduction of P-Mad signal
when Punt is downregulated in muscles (from
left to right, n = 35, 34).
(J) Model of glia-derived Mav signaling. Mav is
secreted by glia and binds to the type II receptor
Punt, which together with an unknown type I
TGF-b receptor phosphorylates postsynaptically
localized Mad. P-Mad dimerizes with the co-
Smad Medea (Med) and translocates into the
muscle nucleus, where it activates Gbb tran-
scription. Muscle Gbb is released by muscles
and retrogradely activates Wit and Tkv or Sax
receptors in presynaptic terminals. This leads to
presynaptic phosphorylation of Mad, which in
a complex with Med translocates into motor
neuron nuclei and activates Trio transcription.
Trio is transported to presynaptic endings, where
it regulates synaptic bouton growth.
Error bars represent mean 6 SEM (***p < 0.001,
**p % 0.01, *p % 0.05). Scale bar represents
10 mm for (D2)–(F2) and 25 mm for (D1)–(F1).
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levels of motor neuron nuclear P-Mad (Figure 4B), suggesting
that the pathways activated by the two ligands diverge [15].
This divergence could result from the use of different receptor
isoforms. For example, the activins Actb and Daw can have
different effects on the same tissues, as a result of differential
interactions with alternative Baboon isoforms [15, 17]. Never-
theless, this work identifies a novel glial synaptogenic factor
and provides compelling evidence for a critical role for glia in
modulation of synapse assembly at the NMJ in vivo.
Experimental Procedures
Drosophila Strains
We used Gli-Gal4 (rl82-Gal4) [18], C57-Gal4 and C380-Gal4 [19], UAS-
mCD8-GFP [20], UAS-mCD8::mCherry (gift from Mary Logan), UAS-Mad-RNAi (ID 12635, Vienna Drosophila RNAi Center [VDRC]), UAS-MYO-RNAi
(ID 33132, VDRC), UAS-Daw-RNAi (ID 105309, VDRC), UAS-Mav-RNAi-1
(generous gift from Tzumin Lee), UAS-Mav-RNAi-2 (ID 1901R-4, National
Institute of Genetics, Japan), UAS-Punt-RNAi-1 (ID 107071, VDRC), UAS-
Punt-RNAi-2 (ID 848, VDRC), and gbb1 [21]. We also generated UAS-Mav
and UAS-Mav-GFP by subcloning wild-type (WT) Mav (or Mav-GFP) cDNA
into the pUAST vector. Transgenic constructs were transformed into w1118
flies by BestGene Inc.
Real-Time PCR
Three independent extractions of total RNA were isolated from dissected
third-instar peripheral nerves, body wall muscles, or larval brain; extracted
with TRIzol (Invitrogen); and purified using an RNeasy Micro Kit (QIAGEN).
First-strand cDNAwas synthesized using Sensiscript RT (QIAGEN) for nerve
RNA or SuperScript III enzyme for brain and BWMRNA with oligo (dT) 12-18
primer (Invitrogen). The following TaqMan primers (Applied Biosystems)
were used: Repo (ID Dm02134815_g1), MYO (ID Dm01820708_g1),
Daw (ID Dm01814209_g1), Mav (ID Dm01825561_g1), Activin b (ID
Control of Synaptic Retrograde Signal by Glia
1837Dm01831511_m1), Gapdh (ID Dm01841185_m1), Dad (ID Dm02134937_m1),
Gbb (ID Dm01843010_s1), Trio (ID Dm01795013_m1), Cyclophilin 1 (ID
Dm01813702_m1), and RpL32 (ribosomal protein L32 [ID Dm02151827_
g1] was our endogenous control gene for brain and body wall muscles).
PCR protocol was 95C for 10 min, followed by 40 cycles of 95C for 15 s
and 60C for 1 min. Real-time curves were monitored using –RT as negative
controls and WT embryos as positive control for the primers. Data were
analyzed via the delta-delta Ct method [22]. PCR products were run on
agarose gel (see Figure 1A) and sequenced to verify gene identity. As a
negative control, cDNA from brain and nerve was PCR amplified with either
Elav (forward: CGCATGCTGGCGTAGGCACACC; reverse: CGAAAGTTG
TAGGTTTGGACACGG) or Gapdh (forward: ACTCGACTCACGGTCGTTTC;
reverse: GCCGAGATGATGACCTTCTT) primers.
Immunolabeling and Confocal Microscopy
Third-instar Drosophila larval body wall muscles were dissected in calcium-
free saline [23] and fixed for 10 min with nonalcoholic Bouin’s fixative unless
otherwise noted. Larval brains were fixed with 4% paraformaldehyde in 0.1
phosphate buffer (pH 7.4) for 1 hr. Primary antibodies were anti-P-Mad
(1:100, Cell Signaling), anti-Elav (Developmental Studies Hybridoma Bank
[DSHB]), anti-GluRIIA (1:3, DSHB), anti-DLG (1:20,000 [24]), anti-GFP
(1:200, Molecular Probes), nc82 (anti-Brp, 1:100, DSHB), anti-Mav (1:50,
see below), and fluorescein isothiocyanate (FITC) or Texas red-conjugated
anti-horseradish peroxidase (HRP; 1:200, Jackson ImmunoResearch).
Secondary antibodies conjugated to DyLight 488, 594, or 649 (Jackson
ImmunoResearch) were used at 1:200. Samples were imaged using
an Intelligent Imaging Innovations Everest spinning-disk confocal system
with a PlanApo 633 1.4 NA oil lens and analyzed with ImageJ (1.45I)
software.
Generation of Mav Antibody
Affinity-purified chicken anti-Mav antibody was generated by 21st Century
Biochemicals using a peptide encompassing amino acids 371–389 of
Mav-PA (C-PLTNAQDANFHHDKIDEA-N-amide).
Quantifications
Samples used for quantification were processed simultaneously and confo-
caled in the same imaging session using identical acquisition parameters.
The percentage of P-Mad-positive boutons was quantified for type 1b bou-
tons from preparations double labeled with anti-HRP and P-Mad antibodies
by counting the number of boutons containing P-Mad signal and expressing
it as a percentage of total bouton number. To analyze the P-Mad subcellular
localization, we used samples in which we knocked down Mad in muscle or
motor neurons. We used Volocity software (5.5.1) to detect positive puncta
and calculated P-Mad intensities normalized to HRP volume and subse-
quently normalized to WT. To measure synaptic P-Mad fluorescence inten-
sity, NMJs (muscles 6 and 7, segment A3) from ten different larvae of each
genotype, we blindly choseWT control or glial Mav overexpression animals.
The P-Mad puncta within boutons were then manually selected and the
mean intensity of the P-Mad label was quantified using ImageJ (1.45I).
The data are shown as P-Mad fluorescence mean intensity.
The intensity of motor neuron nuclei P-Mad signal was quantified in
confocal slices in the dorsal region of the CNS cell cortex containing motor
neuron cell bodies in preparations double labeled with anti-Elav and P-Mad
antibodies. Total intensity of P-Mad signal was measured within the Elav-
positive boundary, which marks the motor neuron nuclei, using ImageJ
(1.45I). Intensities were normalized to WT controls.
Branch number was measured at muscles 6 and 7 (abdominal segment 3)
starting at the primary neurite, where the axon first meets the muscle, and
scoring each neurite after a branch point. For example, if a single neurite
branched into a ‘‘Y’’ formation, it was scored as a 3.
Statistical Analysis
Unpaired two-tailed Student’s t tests were run for comparisons of experi-
ments in which a single experimental sample was processed in parallel
with a WT control. In cases where multiple experimental groups were
compared to a single control, a one-way ANOVA was performed with
Dunnett’s post hoc test. Error bars in all graphs represent 6 SEM.
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